Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life

NCT01742143 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT01742143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01742143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2012
Completion date
November 30, 2027
Enrollment
347 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients